Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Cortes

Showing results (121-130 of 791) with videos related to

Pageof 80
Sort By:
Expert Opinion on Pharmacotherapy|July 24, 2013
Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemiaAziz Nazha, Hagop Kantarjian, Jorge Cortes, et al.
Haematologica|October 5, 2013
The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemiaAziz Nazha, Carlos G Romo, Hagop Kantarjian, et al.
Expert Opinion on Investigational Drugs|June 14, 2008
Nilotinib: a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemiasElias Jabbour, Samih El Ahdab, Jorge Cortes, et al.
Blood|May 6, 2009
Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemiaAlfonso Quintás-Cardama, Xin Han, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failureA Megan Cornelison, Hagop Kantarjian, Jorge Cortes, et al.
Current Hematologic Malignancy Reports|April 29, 2010
New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemiaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Hematology/Oncology Clinics of North America|November 8, 2011
Chronic myeloid leukemia: mechanisms of resistance and treatmentElias Jabbour, Sameer A Parikh, Hagop Kantarjian, et al.
JAMA Oncology|July 17, 2015
Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary ReviewTapan M Kadia, Farhad Ravandi, Jorge Cortes, et al.
American Journal of Hematology|May 17, 2007
Normal hematopoietic function and multiple bone marrow clonal abnormalities in a patient with acute myeloid leukemia after two mismatched stem-cell transplants with graft failure and autologous reconstitutionFabiana Ostronoff, Carlos Bueso-Ramos, Jorge Cortes, et al.
Blood|April 24, 2007
Congestive heart failure is a rare event in patients receiving imatinib therapyEhab Atallah, Jean-Bernard Durand, Hagop Kantarjian, et al.
Pageof 80

Showing results (121-130 of 791) with videos related to

Sort By:
Pageof 80
Expert Opinion on Pharmacotherapy|July 24, 2013
Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemiaAziz Nazha, Hagop Kantarjian, Jorge Cortes, et al.
Haematologica|October 5, 2013
The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemiaAziz Nazha, Carlos G Romo, Hagop Kantarjian, et al.
Expert Opinion on Investigational Drugs|June 14, 2008
Nilotinib: a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemiasElias Jabbour, Samih El Ahdab, Jorge Cortes, et al.
Blood|May 6, 2009
Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemiaAlfonso Quintás-Cardama, Xin Han, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failureA Megan Cornelison, Hagop Kantarjian, Jorge Cortes, et al.
Current Hematologic Malignancy Reports|April 29, 2010
New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemiaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Hematology/Oncology Clinics of North America|November 8, 2011
Chronic myeloid leukemia: mechanisms of resistance and treatmentElias Jabbour, Sameer A Parikh, Hagop Kantarjian, et al.
JAMA Oncology|July 17, 2015
Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary ReviewTapan M Kadia, Farhad Ravandi, Jorge Cortes, et al.
American Journal of Hematology|May 17, 2007
Normal hematopoietic function and multiple bone marrow clonal abnormalities in a patient with acute myeloid leukemia after two mismatched stem-cell transplants with graft failure and autologous reconstitutionFabiana Ostronoff, Carlos Bueso-Ramos, Jorge Cortes, et al.
Blood|April 24, 2007
Congestive heart failure is a rare event in patients receiving imatinib therapyEhab Atallah, Jean-Bernard Durand, Hagop Kantarjian, et al.
Pageof 80